These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 37665951)
1. SOCS1 acts as a ferroptosis driver to inhibit the progression and chemotherapy resistance of triple-negative breast cancer. Wang Y; Pang X; Liu Y; Mu G; Wang Q Carcinogenesis; 2023 Dec; 44(8-9):708-715. PubMed ID: 37665951 [TBL] [Abstract][Full Text] [Related]
2. SOCS1 is associated with clinical progression and acts as an oncogenic role in triple-negative breast cancer. Qian Q; Lv Y; Li P IUBMB Life; 2018 Apr; 70(4):320-327. PubMed ID: 29527785 [TBL] [Abstract][Full Text] [Related]
3. Gold nanoparticles attenuate the interferon-γ induced SOCS1 expression and activation of NF-κB p65/50 activity via modulation of microRNA-155-5p in triple-negative breast cancer cells. Farhana A; Alsrhani A; Rasheed N; Rasheed Z Front Immunol; 2023; 14():1228458. PubMed ID: 37720228 [TBL] [Abstract][Full Text] [Related]
4. miR-4458 regulates cell proliferation and apoptosis through targeting SOCS1 in triple-negative breast cancer. Liu X; Wang J; Zhang G J Cell Biochem; 2019 Aug; 120(8):12943-12948. PubMed ID: 30873664 [TBL] [Abstract][Full Text] [Related]
5. LncRNA HEIH regulates cell proliferation and apoptosis through miR-4458/SOCS1 axis in triple-negative breast cancer. Li P; Zhou B; Lv Y; Qian Q Hum Cell; 2019 Oct; 32(4):522-528. PubMed ID: 31456112 [TBL] [Abstract][Full Text] [Related]
6. SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis. Song X; Wang X; Chen X; Yu Z; Zhou Y J Proteomics; 2024 Feb; 292():105055. PubMed ID: 38040194 [TBL] [Abstract][Full Text] [Related]
7. POU2F2-mediated upregulation of lncRNA Li J; Li PT; Wu W; Ding BN; Wen YG; Cai HL; Liu SX; Hong T; Zhang JF; Zhou JD; Qian LY; Du J Epigenomics; 2024 Feb; 16(4):215-231. PubMed ID: 38318853 [TBL] [Abstract][Full Text] [Related]
8. WTAP Mediates NUPR1 Regulation of LCN2 Through m Tan M; He Y; Yi J; Chen J; Guo Q; Liao N; Peng L Biochem Genet; 2024 Apr; 62(2):876-891. PubMed ID: 37477758 [TBL] [Abstract][Full Text] [Related]
9. IL-13 facilitates ferroptotic death in asthmatic epithelial cells via SOCS1-mediated ubiquitinated degradation of SLC7A11. Miao M; Pan M; Chen X; Shen J; Zhang L; Feng X; Chen M; Cui G; Zong H; Zhang W; Chang S; Xu F; Wang Z; Li D; Liu W; Ding Z; Zhang S; Chen B; Zha X; Fan X Redox Biol; 2024 May; 71():103100. PubMed ID: 38484644 [TBL] [Abstract][Full Text] [Related]
10. PTGER3 knockdown inhibits the vulnerability of triple-negative breast cancer to ferroptosis. Wang S; Zhang Y; Zhang D; Meng J; Che N; Zhao X; Liu T Cancer Sci; 2024 Jun; 115(6):2067-2081. PubMed ID: 38566528 [TBL] [Abstract][Full Text] [Related]
11. Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells. Du J; Wang L; Huang X; Zhang N; Long Z; Yang Y; Zhong F; Zheng B; Lan W; Lin W; Ma W Phytomedicine; 2021 May; 85():153551. PubMed ID: 33827043 [TBL] [Abstract][Full Text] [Related]
12. Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells. Lei M; Zhang YL; Huang FY; Chen HY; Chen MH; Wu RH; Dai SZ; He GS; Tan GH; Zheng WP Sci Rep; 2023 Dec; 13(1):21916. PubMed ID: 38081931 [TBL] [Abstract][Full Text] [Related]
13. PGM5P3-AS1 regulates MAP1LC3C to promote cell ferroptosis and thus inhibiting the malignant progression of triple-negative breast cancer. Qi L; Sun B; Yang B; Lu S Breast Cancer Res Treat; 2022 Jun; 193(2):305-318. PubMed ID: 35325342 [TBL] [Abstract][Full Text] [Related]
14. A Novel Derivative of Curcumol, HCL-23, Inhibits the Malignant Phenotype of Triple-Negative Breast Cancer and Induces Apoptosis and HO-1-Dependent Ferroptosis. Zhao P; Song H; Gao F; Chen L; Qiu J; Jin J; Pan C; Tang Y; Chen M; Pan Y; Li Y; Huang L; Yang J; Hao X Molecules; 2023 Apr; 28(8):. PubMed ID: 37110625 [TBL] [Abstract][Full Text] [Related]
15. Danggui Buxue Tang improves therapeutic efficacy of doxorubicin in triple negative breast cancer via ferroptosis. Gong G; Ganesan K; Liu Y; Huang Y; Luo Y; Wang X; Zhang Z; Zheng Y J Ethnopharmacol; 2024 Apr; 323():117655. PubMed ID: 38158099 [TBL] [Abstract][Full Text] [Related]
16. MaiJiTong granule attenuates atherosclerosis by reducing ferroptosis via activating STAT6-mediated inhibition of DMT1 and SOCS1/p53 pathways in LDLR Shi J; Yang MM; Yang S; Fan F; Zheng G; Miao Y; Hua Y; Zhang J; Cheng Y; Liu S; Guo Y; Guo L; Yang X; Fan G; Ma C Phytomedicine; 2024 Jun; 128():155489. PubMed ID: 38569295 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism. Li P; Lin Q; Sun S; Yang N; Xia Y; Cao S; Zhang W; Li Q; Guo H; Zhu M; Wang Y; Zheng Z; Li S Cell Death Dis; 2022 Sep; 13(9):808. PubMed ID: 36130940 [TBL] [Abstract][Full Text] [Related]
18. Effect of SOCS1 silencing on proliferation and apoptosis of melanoma cells: An in vivo and in vitro study. Yu SJ; Long ZW Tumour Biol; 2017 May; 39(5):1010428317694315. PubMed ID: 28466787 [TBL] [Abstract][Full Text] [Related]
19. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells. Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669 [TBL] [Abstract][Full Text] [Related]
20. Gallium maltolate shows synergism with cisplatin and activates nucleolar stress and ferroptosis in human breast carcinoma cells. Chen CH; Huang YM; Grillet L; Hsieh YC; Yang YW; Lo KY Cell Oncol (Dordr); 2023 Aug; 46(4):1127-1142. PubMed ID: 37067747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]